4,4',4''-(1H-Imidazole-2,4,5-triyl)tripyridine

Catalog No.: 
ACLBHO897
CAS No.: 
23974-93-8
Molecular Formula: 
C18H13N5
Molecular Weight: 
299.34
4,4',4''-(1H-Imidazole-2,4,5-triyl)tripyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$63.00In stockIn stock
5g97%$232.00In stockIn stock
25g97%$1125.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,4',4''-(1H-Imidazole-2,4,5-triyl)tripyridine
IUPAC Name4,4',4''-(1H-imidazole-2,4,5-triyl)tripyridine
Molecular FormulaC18H13N5
Molecular Weight299.34
SMILESC1(C2=CC=NC=C2)=NC(C3=CC=NC=C3)=C(C4=CC=NC=C4)N1
InChI KeyYJOAHXHOXMAHOG-UHFFFAOYSA-N
Synonym4,4',4''-(1H-imidazole-2,4,5-triyl)tripyridine;Pyridine, 4,4',4''-(1H-imidazole-2,4,5-triyl)tris-;2,4,5-Tris(4-pyridyl)imidazole;4,4',4''-(1H-Imidazole-2,4,5-triyl)tris[pyridine];Pyridine, 4,4',4''-imidazole-2,4,5-triyltri- (8CI);DK7534;2,4,5-tris(4-pyridinyl)imidazole
CAS No.23974-93-8
PubChem CID11415329

Synthetic Route by SureRoute

1. ACLBHO897 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIDLP204 route compound structure diagram
    ACIDLP204913835-65-1In Stock
  4. Then
  5. ACLBHO897 route product structure diagram
    ACLBHO89723974-93-8In Stock
Inquiry

2. ACLBHO897 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEXLC102 route compound structure diagram
    ACEXLC1026345-27-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLBHO897 route product structure diagram
    ACLBHO89723974-93-8In Stock
Inquiry

3. ACLBHO897 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLBHO897 route product structure diagram
    ACLBHO89723974-93-8In Stock
Inquiry

Comments (0)